Pinealon: Preclinical neurological research

Pinealon is a tripeptide examined in neurological and oxidative-stress experiments. The cited evidence is preclinical and does not establish a human memory benefit for a product.

What the research shows

A 2012 rat study used a model involving elevated homocysteine during pregnancy and assessed offspring learning and biological markers. This specific model is neither a patient-treatment trial nor evidence recommending use during human pregnancy. [1] [2]

Distinguishing substances and products

Pinealon differs from Semax, Selank and Cerebrolysin. A shared neurological topic does not make their research or product documentation interchangeable.

Reading a specific brand’s label

Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.

Frequently asked questions

What kind of Pinealon evidence is cited here?

A preclinical rat study, not a human efficacy trial of a branded product.

Do rat-offspring findings establish human memory benefits?

No. Relevant human outcome studies are needed.

What information helps identify a specific product?

The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.

Related information

For general questions about names or label details, contact LINE: @musclestationth

Sources and review date

  1. Pinealon rat study, 2012
  2. Full text of the same Pinealon study

Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.

Home
Catalog
LINE
Facebook
Scroll to Top